To the Editor
The non-obese diabetic (NOD) mouse is an established and widely used model of autoimmune type I diabetes1. Besides the involvement of class II-and class I-restricted T cells, additional major histocompatibility complex (MHC) and non-MHC-linked genetic factors contribute to disease susceptibility2. Faustman and colleagues claim that in NOD mice the expression of the IFNγ-inducible large multifunctional proteasome subunit 2 (LMP2; Genome Database designation, PSMB9) is decreased both at the mRNA and protein level3,4. In addition, they noted a failure to appropriately activate NFκB in cells from NOD mice due to defective IκB degradation. This observation was attributed to the claimed defect in LMP2 synthesis. While the published data show that activation of NFκB relies on proteasomal proteolysis, there is no independent evidence that such activation would require the specific involvement of LMP2-bearing proteasomes5.
We examined the expression of LMP2 mRNA by real time PCR and found no evidence for impaired transcription of the LMP2 gene in NOD mice as compared to BALB/c mice (Fig. 1a). Further, immunoblot analysis showed no reduction of LMP2, LMP7 and MECL1 protein levels in NOD mice, compared to other strains (Fig. 1b). The slight differences in mobility of LMP2 and LMP7 proteins on SDS PAGE are attributable to their genetic polymorphism. What about proteasome activity? The assessment of proteasomal proteolysis in crude extracts using fluorogenic substrates is complicated by the presence of other non-proteasomal peptidases. We therefore analyzed directly the content of cell extracts for active proteasome β subunits using a mechanism-based active site directed probe6. We observed normal proteasome activity in extracts from thymus and spleen of NOD mice (Fig. 1c). Active immunoproteasomes including LMP2 are present at comparable levels in all strains analyzed, and did not appear to be influenced by age, gender or the presence or absence of diabetes (Fig. 1c and data not shown). LMP2, together with LMP7 and MECL1 are essential subunits for the assembly of the immunoproteasome7. Mere overexpression of a single immunoproteasome subunit does not lead to assembly of functional immunoproteasomes, and conversely, the ablation of either LMP2 or LMP7 suffices to eliminate formation of immunoproteasomes which contain all three interferon-γ-inducible β subunits8. Thus, the absence of LMP2, as claimed by Faustman and coworkers, should have abolished the activity of immunoproteasomes altogether.
In summary, our data show normal LMP2 expression and proteasome activity in NOD mice. Consequently, there is no reason to entertain the possibility that compromised proteasomal function would cause diabetes in NOD mice. A failure to activate NFκB is not addressed by our analysis and, if confirmed independently, remains a factor that could contribute to the NOD phenotype.
References
Castano, L. & Eisenbarth, G.S. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8, 647–679 (1990).
Cordell, H.J. & Todd, J.A. Multifactorial inheritance in type 1 diabetes. Trends Genet. 11, 499–504 (1995).
Yan, G., Fu Y. & Faustman, D.L. Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter. J. Immunol. 159, 3068–3080 (1997).
Hayashi, T. & Faustman, D. NOD mice are defective in proteasome production and activation of NF-κB. Mol. Cell. Biol. 19, 8646–8659 (1999).
Palombella, V.J., Rando, O.J., Goldberg, A.L. & Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78, 773–785 (1994).
Bogyo, M., Shin, S., McMaster, J.S. & Ploegh, H.L. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem. Biol. 5, 307–320 (1998).
Tanaka, K., Tanahashi, N., Tsurumi, C., Yokota, K.Y. & Shimbara, N. Proteasomes and antigen processing. Adv. Immunol. 64, 1–38 (1997).
Griffin, T.A. et al. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-γ)-inducible subunits. J. Exp. Med. 187, 97–104 (1998).
Nandi, D., Iyer, M.N. & Monaco, J.J. Molecular and serological analysis of polymorphisms in the murine major histocompatibility complex-encoded proteasome subunits, LMP-2 and LMP-7. Exp. Clin. Immunogenetics 13, 20–29 (1996).
Salter, R.D., Howell, D.N. & Cresswell, P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21, 235–246 (1985).
Nandi, D., Woodward, E., Ginsburg, D.B. & Monaco, J.J. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits. EMBO J. 16, 5363–5375 (1997).
Van Kaer, L. et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1, 533–541 (1994).
Makino, S. et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29, 1–13 (1980).
Stephens, L.A., Thomas, H.E. & Kay, T.W. Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-κB. J. Autoimmun. 10, 293–298 (1997).
Sears, C., Olesen, J., Rubin, D., Finley, D. & Maniatis, T. NF-κB p105 processing via the ubiquitin-proteasome pathway. J. Biol. Chem. 273, 1409–1419 (1998).
Gueckel, R., Enenkel, C., Wolf, D.H. & Hilt, W. Mutations in the yeast proteasome beta-type subunit Pre3 uncover position-dependent effects on proteasomal peptidase activity and in vivo function. J. Biol. Chem. 273, 19443–19452 (1998).
Acknowledgements
This work was supported in part by the Juvenile Diabetes Foundation International through the Juvenile Diabetes Foundation Center for Islet Transplantation at HarvardMedical School. We thank D.Mathis and C.Benoist from the Joslin Diabetes center for sharing the B6.H-2g7 mice. B.M.K was supported by a long-term fellowship from the Human Frontier Science Program Organisation, and A.-M.L.-D. by a Juvenile Diabetes Foundation postdoctoral fellowship.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kessler, B., Lennon-Duménil, AM., Shinohara, M. et al. LMP2 expression and proteasome activity in NOD mice. Nat Med 6, 1064 (2000). https://doi.org/10.1038/80346
Issue Date:
DOI: https://doi.org/10.1038/80346
This article is cited by
-
A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice
British Journal of Cancer (2012)